The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 32 | — | 20.1x | Below average | |
Growth | 14 | -77.6% | 5.6% | Below average | |
Quality | 7 | -154.8% | 7.6% | Below average | |
Safety | 34 | 0.4x | 0.4x | Below average | |
Capital Return | 41 | — | 2.19% | Near average | |
Momentum | — | — | — | No data | |
Sentiment | — | — | — | No data |
CervoMed Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy CervoMed Inc. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
CervoMed stock has seen a notable stability in its target price at $9, with an increase in the number of analysts covering the stock from 2 to 3 over the past 30 days. This complete consensus (Zero Dispersion) among the three analysts on the same price target indicates high and unified confidence in the stock's fair value, despite the significant gap between the current price (3.06) and the target.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.